top of page

Welcome to Nivagen Pharmaceuticals

Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. Our vision is to deliver high quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world.

CG Launch.jpg

Growth through Global Partnerships

Acquisition and Licensing Model

The US generic market is large and growing. The market is complex and fragmented and requires a variety of infrastructures to reach all major channels and segments


Every business has its individual core strengths. One of Nivagen’s core strengths is the ability of our sales team to launch new generic products in the US market.

Product Development / Co-Development Model

Nivagen's business model is to identify and utilize the world`s best and economical CROs and CRAMs to develop and manufacture niche generic and OTC products.

Upcoming Events

Come Meet With Us

Shaking Hands

Nivagen will be at the following events in 2023-2024:


  • CPhI North America 2023 – April 25-27, in Philadelphia, Pennsylvania

  • HDA Business and Leadership Conference 2023- June 11-14, in Colorado Springs, Colorado

  • NACDS Total Store Expo 2023 – August 12-14, in San Diego, California

  • CPhI Worldwide 2023 – October 24-26, in Barcelona, Spain

  • ECRM Retail Pharmacy – Generic Rx 2024

  • DCAT Week 2024– March 18-21, in New York City, New York

Contact Us

If you have any questions, concerns, product complaints, or adverse drug events (ADEs) regarding any of our products, Please contact us at:
Phone: 1-877-977-0687
             1- 916-364-1662
Fax: 844-270-3131
Email: /


For all other inquiries, please use the form below:

  • LinkedIn

Find us on LinkedIn

Contact Us
bottom of page